首页|期刊导航|中国肺癌杂志|LINC00641调节miR-1306-5p/FGFR3轴对非小细胞肺癌H1299细胞恶性进展和化疗耐药性的影响

LINC00641调节miR-1306-5p/FGFR3轴对非小细胞肺癌H1299细胞恶性进展和化疗耐药性的影响OA

Effects of LINC00641 on the Malignant Progression and Chemotherapy Resistance of Non-small Cell Lung Cancer H1299 Cells by Regulating the miR-1306-5p/FGFR3 Axis

中文摘要英文摘要

背景与目的 非小细胞肺癌(non-small cell lung cancer,NSCLC)是全球癌症相关死亡的原因之一,尽管以铂类为基础的化疗是晚期患者的主要治疗手段,但获得性耐药常导致治疗失败.长链非编码RNA(long non-coding RNA,lncRNA)在肿瘤发生发展中扮演重要角色,但其在NSCLC化疗耐药中的具体机制尚不完全清楚.本研究旨在探讨LINC00641调节微小RNA-1306-5p(microRNA-1306-5p,miR-1306-5p)/成纤维细胞生长因子受体3(fibroblast growth factor receptor 3,FGFR3)轴对NSCLC细胞H1299恶性进展和化疗耐药性的影响.方法 实时荧光定量聚合酶链式反应(quantitative real-time polymerase chain reaction,qRT-PCR)法检测mRNA表达;双荧光素酶报告基因实验验证互作.将H1299细胞随机分为CG组(正常培养)、sh-NC组(转染sh-NC)、sh-LINC00641组(转染sh-LINC00641)、sh-LINC00641+anti-NC组(转染sh-LINC00641+anti-NC)、sh-LINC00641+anti-miR-1306-5p组(转染sh-LINC00641+anti-miR-1306-5p)、mimic-NC组(转染mimic-NC)、miR-1306-5p-mimics组(转染miR-1306-5p-mimics)、miR-1306-5p-mimics+OE-NC组(转染miR-1306-5p-mimics+OE-NC)、miR-1306-5p-mimics+OE-FGFR3组(转染miR-1306-5p-mimics+OE-FGFR3).平板克隆形成实验、划痕实验检测细胞迁移,Transwell实验检测细胞迁移和侵袭;另将H1299/DDP细胞按上述进行分组,MTT法检测H1299/DDP细胞化疗耐药性;Western blot检测H1299细胞中FGFR3、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)、基质金属蛋白酶13(matrix metal-loproteinase 13,MMP-13)、整合素β1(integrin β1)以及H1299/DDP细胞中P-糖蛋白(P-glycoprotein,P-gp)、多药耐药相关蛋白1(multidrug resistance-associated protein 1,MRP1)蛋白表达.结果 NSCLC组织或细胞(H1299、H1299/DDP)中LINC00641、FGFR3高表达,miR-1306-5p低表达,且耐药细胞H1299/DDP中3个因子表达趋势变化更明显(P<0.05).LINC00641可以靶向负调控miR-1306-5p;miR-1306-5p可以靶向负调控FGFR3.敲低sh-LINC00641或过表达miR-1306-5p能够降低H1299细胞克隆数、划痕愈合率、迁移数、侵袭数以及细胞中PCNA、MMP-13、integrin β1蛋白表达(P<0.05),并可以抑制H1299/DDP细胞吸光度(optical density,OD)540值以及细胞中P-gp、MRP1蛋白表达(P<0.05).抑制miR-1306-5p或过表达FGFR3可逆转敲低sh-LINC00641或过表达miR-1306-5p对H1299细胞增殖、迁移、侵袭和化疗耐药性的抑制作用(P<0.05).结论 敲低LINC00641可以调节miR-1306-5p/FGFR3轴,抑制NSCLC细胞恶性进展和化疗耐药性,为NSCLC化疗耐药的分子干预提供了新的候选靶点.

Background and objective Non-small cell lung cancer(NSCLC)is one of the causes of cancer-related deaths worldwide.Although platinum-based chemotherapy is the main treatment method for advanced patients,acquired resistance often leads to treatment failure.Long non-coding RNAs(lncRNAs)play an important role in tumor occurrence and development,but the specific mechanism of their involvement in chemotherapy resistance in NSCLC is not yet fully un-derstood.This study aims to explore the effect of LINC00641 on the microRNA-1306-5p(miR-1306-5p)/fibroblast growth factor receptor 3(FGFR3)axis on the malignant progression and chemotherapy resistance of NSCLC cell line H1299.Meth-ods The mRNA expression was detected by quantitative real-time polymerase chain reaction(qRT-PCR);and the interaction was verified by the dual-luciferase reporter gene assay.H1299 cells were randomly divided into the following groups:CG group(normal culture),sh-NC group(transfected with sh-NC),sh-LINC00641 group(transfected with sh-LINC00641),sh-LINC00641+anti-NC group(transfected with sh-LINC00641 and anti-NC),sh-LINC00641+anti-miR-1306-5p group(transfected with sh-LINC00641 and anti-miR-1306-5p),mimic-NC group(transfected with mimic-NC),miR-1306-5p-mimics group(transfected with miR-1306-5p-mimics),miR-1306-5p-mimics+OE-NC group(transfected with miR-1306-5p-mimics and OE-NC),and miR-1306-5p-mimics+OE-FGFR3 group(transfected with miR-1306-5p-mimics and OE-FGFR3).Then cell proliferation,migration,and invasion were measured by plate colony formation assay,scratch assay,and Transwell assay,respectively.In addition,H1299/DDP cells were grouped as mentioned above.After that,the chemotherapy resistance of H1299/DDP cells was detected by the MTTmethod.And Western blot was implemented to detect the protein expressions of FGFR3,proliferating cell nuclear antigen(PCNA),matrix metalloproteinase 13(MMP-13),integrin β1 in H1299 cells,and the P-glycoprotein(P-gp),multidrug resistance-associated protein 1(MRP1)in H1299/DDP cells.Results In NSCLC tis-sues or cells(H1299,H1299/DDP),LINC00641 and FGFR3 were highly expressed,while miR-1306-5p was lowly expressed,and the expression trends of these three factors changed more significantly in the drug-resistant cell line H1299/DDP(P<0.05).LINC00641 could negatively regulate miR-1306-5p in a targeted manner;and miR-1306-5p could negatively regulate FGFR3 in a targeted manner.Knockdown of LINC00641(sh-LINC00641)or overexpression of miR-1306-5p reduced the clone number,scratch healing rate,migration number,invasion number,and the expression of PCNA,MMP-13,and integrin β1 proteins in H1299 cells(P<0.05),and also suppressed the optical density(OD)540 value and the expression of P-gp and MRP1 proteins in H1299/DDP cells(P<0.05).In addition,inhibition of miR-1306-5p or overexpression of FGFR3 could reverse the inhibitory effects of LINC00641 knockdown or miR-1306-5p overexpression on the proliferation,migration,invasion,and chemoresistance of H1299 cells(P<0.05).Conclusion Knockdown of LINC00641 can regulate the miR-1306-5p/FGFR3 axis,inhibit the malignant progression and chemotherapy resistance of NSCLC cells,and provide a new candidate target for molecular intervention of chemotherapy resistance in NSCLC.

乌日罕;杜予馨;刘彩霞

010050 呼和浩特,内蒙古医科大学附属医院内蒙古医科大学第一临床医学院010050 呼和浩特,内蒙古医科大学附属医院

肺肿瘤长链非编码RNA00641微小RNA-1306-5p成纤维细胞生长因子受体3恶性进展化疗耐药性

Lung neoplasmsLong non-coding RNA00641MicroRNA-1306-5pFibroblast growth factor recep-tor 3Malignant progressionChemotherapy resistance

《中国肺癌杂志》 2026 (4)

263-277,15

本研究受内蒙古医科大学附属医院资助项目(No.2022NYFYFG010)、内蒙古自治区教育厅资助项目(No.NJZY23154)、内蒙古医科大学资助项目(No.ZY20242137)及北京市希思科临床肿瘤学研究基金会资助项目(No.YHH202101-0275)资助 This study was supported by the grants from the Funding Project of Affiliated Hospital of Inner Mongolia Medical Uni-versity(No.2022NYFYFG010,to Caixia LIU),Funding Project of Inner Mongolia Education Department(No.NJZY23154,to Caixia LIU),Funding Project of Inner Mongolia Medical University(No.ZY20242137,to Caixia LIU),Funding Project of Beijing Sicheng Clinical Oncology Research Foundation(No.YHH202101-0275,to Caixia LIU).

10.3779/j.issn.1009-3419.2026.101.10

评论